(Q33204826)

23 July 2017

title

Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1). (English)

1 reference

23 July 2017

1 reference

David J Schneider

1

1 reference

23 July 2017

Michael Hayes

2

1 reference

23 July 2017

Marilyn Wadsworth

3

1 reference

23 July 2017

Heidi Taatjes

4

1 reference

23 July 2017

Mercedes Rincón

5

1 reference

23 July 2017

Douglas J Taatjes

6

1 reference

23 July 2017

Burton E Sobel

7

1 reference

23 July 2017

publication date

1 August 2004

1 reference

Journal of Histochemistry and Cytochemistry

23 July 2017

published in

1 reference

23 July 2017

volume

52

1 reference

23 July 2017

issue

8

1 reference

23 July 2017

page(s)

1091-1099

1 reference

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Coronary Plaque Disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Cell-associated plasminogen activation: regulation and physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Structure and expression of a smooth muscle cell-specific gene, SM22 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Improved quantitative characterization of atherosclerotic plaque composition with immunohistochemistry, confocal fluorescence microscopy, and computer-assisted image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6260.2004

21 January 2018

Identifiers

DOI

10.1369/JHC.4A6260.2004

1 reference

23 July 2017

1 reference